BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29775158)

  • 1. microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer.
    Zedan AH; Hansen TF; Assenholt J; Pleckaitis M; Madsen JS; Osther PJS
    Tumour Biol; 2018 May; 40(5):1010428318775864. PubMed ID: 29775158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-Free miRNA-141 and miRNA-205 as Prostate Cancer Biomarkers.
    Osipov ID; Zaporozhchenko IA; Bondar AA; Zaripov MM; Voytsitskiy VE; Vlassov VV; Laktionov PP; Morozkin ES
    Adv Exp Med Biol; 2016; 924():9-12. PubMed ID: 27753010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy.
    Zedan AH; Hansen TF; Assenholt J; Madsen JS; Osther PJS
    Prostate; 2019 Mar; 79(4):425-432. PubMed ID: 30537232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs are correlated with tumor progression in prostate cancer.
    Brase JC; Johannes M; Schlomm T; Fälth M; Haese A; Steuber T; Beissbarth T; Kuner R; Sültmann H
    Int J Cancer; 2011 Feb; 128(3):608-16. PubMed ID: 20473869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
    Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW
    Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
    Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
    PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
    Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
    PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
    Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
    Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
    Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and clinical significance of GTP-binding RAS-like 3 (ARHI) and microRNA 221 and 222 in prostate cancer.
    Lin D; Cui F; Bu Q; Yan C
    J Int Med Res; 2011; 39(5):1870-5. PubMed ID: 22117988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
    Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the Level of Circulating hsa-miR-297 and hsa-miR-19b-3p miRNA Are Associated with Generalization of Prostate Cancer.
    Osip'yants AI; Knyazev EN; Galatenko AV; Nyushko KM; Galatenko VV; Shkurnikov MY; Alekseev BY
    Bull Exp Biol Med; 2017 Jan; 162(3):379-382. PubMed ID: 28091918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
    Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD
    Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of microRNA signature and potential pathway targets in prostate cancer.
    Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miRNA-182 and miRNA-187 as potential biomarkers in prostate cancer and its correlation with the staging of prostate cancer.
    Nayak B; Khan N; Garg H; Rustagi Y; Singh P; Seth A; Dinda AK; Kaushal S
    Int Braz J Urol; 2020; 46(4):614-623. PubMed ID: 32213205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Inflammation Induced by microRNAs: Endometriosis-Derived Alterations in Circulating microRNA 125b-5p and Let-7b-5p Regulate Macrophage Cytokine Production.
    Nematian SE; Mamillapalli R; Kadakia TS; Majidi Zolbin M; Moustafa S; Taylor HS
    J Clin Endocrinol Metab; 2018 Jan; 103(1):64-74. PubMed ID: 29040578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Level Expression of microRNA-21 in Peripheral Blood Mononuclear Cells Is a Diagnostic and Prognostic Marker in Prostate Cancer.
    Huang W; Kang XL; Cen S; Wang Y; Chen X
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):469-75. PubMed ID: 26247873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
    Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.